JM Financial Apex PMS Review
| What Works | What Doesn’t |
|---|---|
| Consistent positive alpha over every disclosed period — 1-year (+11.34%), 2-year (+3.25%), 3-year (+4.95%) and since inception (+4.53%) — against its passive benchmark | Stock count, average market cap and sector weights aren’t publicly published for this strategy — standard practice for many PMS providers, but worth requesting from JM Financial as part of your due diligence before you commit |
| 3-year return (17.48%) modestly ahead of the active flexi-cap mutual fund category average (~16.28%) | Only 3 years, 4 months old, with no track record through a genuine market drawdown or a full cycle |
| Investor-friendly fee structure — a choice between a pure fixed fee or a lower fixed fee plus performance fee | A flexi-cap mandate sits in the same broad universe as your existing flexi-cap and multi-cap mutual funds — worth confirming with the manager whether the holdings meaningfully differ |
| No exit load in any year — genuinely flexible to enter or leave | The investment approach blends “quality” investing with momentum and technical parameters — an unusual combination worth understanding before you commit |
| Credentialed, publicly recognised fund manager with a long, verifiable market-facing career | Since-inception alpha (+4.53%) is solid, but it’s a single, largely favourable market window — not yet proof the edge holds across a full cycle |
Verdict: JM Financial’s Apex strategy has, so far, done the one thing that matters most in year one, two, three and since inception: it has beaten its benchmark, and modestly beaten the average actively managed flexi-cap mutual fund too.
That’s a genuinely good start. What holds this review back from an unqualified “yes” is what a three-year track record simply can’t tell you yet — how the strategy behaves when markets turn, and how its holdings actually compare to what you may already own.
The public data we used doesn’t include portfolio-level detail; that’s worth requesting directly from JM Financial before you size a position.
Before you read another word, understand the only test that actually matters for a fee-based product:
Gross Alpha > Fee = Value Added | Gross Alpha ≈ Fee = Break-Even | Gross Alpha < Fee = Value Destroyed
We don’t have the fund’s gross-of-fee returns disclosed — only the net returns you actually receive.
So the practical version of this test is simpler: is the net-of-fee return ahead of the benchmark, and ahead of what a comparable actively managed alternative delivers?
On the numbers available, Apex sits in the value-added zone across every period disclosed — 1-year, 2-year and 3-year net returns have all beaten the benchmark, and the 3-year return has also modestly beaten the average actively managed flexi-cap mutual fund. That’s a genuinely strong start for a fee-based product.
But a value framework built on three years of data, none of which includes a serious market correction, is an early read — not a verdict.
That distinction matters for how you use the rest of this review.
JM Financial is a long-established name in Indian capital markets, and its Portfolio Management Services arm runs several strategies alongside Apex, including Focus, Growth and Value, India Resurgent, and India Opportunities. Apex itself is a comparatively new addition to that line-up, launched on 1 February 2023.
| Key Facts | Detail |
|---|---|
| Inception Date | 1 February 2023 |
| Category | PMS – Multi Cap & Flexi Cap |
| Benchmark | S&P BSE 500 TRI |
| AUM (as on 30 June 2026) | ₹638.11 Cr |
| Minimum Investment | ₹50,00,000 |
| Portfolio Age | 3 Years, 4 Months |
| Total Number of Stocks | Not shown in the public summary reviewed — available directly from the fund house |
| Average Market Cap | Not shown in the public summary reviewed — available directly from the fund house |
| Top 5 Sectors / Top 5 Stocks | Not shown in the public summary reviewed — available directly from the fund house |
| SIP / STP | Available |
| Fixed Fee Option | 2.50% (fixed only) |
| Variable Fee Option | 1.00% fixed + 20% profit share above a 10% hurdle |
| Exit Load | Nil — Year 1, 2 and 3 |
| Fund Manager | Ashish Chaturmohta, Managing Director – Portfolio Management Services |
*A note on the gaps above: stock count, average market cap, and sector/stock-level weights aren’t publicly published for this strategy.
That’s standard practice for a number of PMS providers, who typically share this level of detail directly with prospective and existing clients on request.
We’d recommend requesting it from JM Financial as a standard part of due diligence before sizing a position.
The stated investment objective is to achieve capital appreciation by investing primarily in listed equity shares, equity-related instruments and ETF units, following a flexi-cap investing style — meaning no fixed allocation or ceiling across large, mid and small caps.
The stated approach is to focus on good quality businesses and managements with the potential to grow over the long term, “coupled with a variety of momentum and technical parameters.”
That combination is worth pausing on.
Fund manager Ashish Chaturmohta’s public background is built substantially around technical and derivatives analysis — recognitions from Zee Business and Economic Times, regular appearances across CNBC TV18, ET Now, NDTV, Bloomberg UTV and CNBC Awaaz.
A quality-plus-momentum overlay is a coherent, explainable philosophy, and it’s genuinely different from a pure fundamentals-only or pure momentum-only strategy.
The publicly available material we reviewed doesn’t spell out specifics like a stated stock count range, market cap ceiling, or turnover policy — the kind of detail that’s worth asking JM Financial for directly if portfolio construction rules matter to your decision.
Trailing Returns (as of 30th June 2026)
| Period | Apex (Net) | S&P BSE 500 TRI | Alpha |
|---|---|---|---|
| 1 Year | 9.38% | -1.96% | +11.34% |
| 2 Years | 4.77% | 1.52% | +3.25% |
| 3 Years | 17.48% | 12.53% | +4.95% |
| 5 Years | NA | NA | — |
| Since Inception | 18.76% | 14.23% | +4.53% |
The 5-year period shows NA for both fund and benchmark simply because the strategy is only 3 years, 4 months old — this is expected, not a red flag.
This is a genuinely encouraging trailing-returns table, and it deserves to be read as one.
Apex has beaten its benchmark in every single period where a comparison is possible, including a year (the trailing 1-year window) where the benchmark itself was negative.
A momentum-and-quality overlay doing its best relative work in a choppy, range-bound market is exactly the kind of pattern you’d expect from a well-designed process — and its worth taking that at face value rather than looking for a reason to doubt it.
The more useful question isn’t “has it beaten the benchmark” — it clearly has. It’s “has it beaten the realistic alternative,” which is what the next section digs into.
You have a genuine choice on how you pay for this PMS: a 2.50% fixed annual fee, or a lower 1.00% fixed fee plus a 20% profit share above a 10% hurdle.
There is no exit load in any year. Both of these are meaningfully more investor-friendly terms than much of the PMS category typically offers.
Value Comparison on ₹50 Lakhs: The Rupee Picture
Illustrative, using the fund’s own disclosed net-of-fee 3-year return compared against the average return delivered by actively managed flexi-cap mutual fund schemes over the same period.
| Scenario | Return Assumed (Net, 3Y) | Corpus After 3 Years |
|---|---|---|
| JM Financial Apex (Net of PMS fees) | 17.48% | ₹81.1 Lakhs |
| Active Flexi-Cap Mutual Fund Category Average | ~16.28% | ₹78.6 Lakhs |
| S&P BSE 500 TRI (Passive Benchmark) | 12.53% | ₹71.3 Lakhs |
Here’s the honest reading: over the last three years, ₹50 lakhs in Apex would have compounded to roughly ₹2.5 lakhs more than the same amount in the average actively managed flexi-cap mutual fund, and about ₹9.8 lakhs more than a passive index tracking the benchmark.
That’s a real, if modest, edge over the more realistic alternative — the average active flexi-cap fund — not just an easy win against a “do nothing” passive option.
Two honest caveats belong right next to that number.
First, this is a single 3-year window, not a multi-cycle track record — the category-average comparison itself is based on a similarly short, largely bull-market-favourable period for most funds in that data set.
Second, a ~1.2 percentage point edge over the category average is real but not dramatic; it’s the kind of gap that can close or reverse over a different 3-year stretch, especially once the strategy is tested by a genuine drawdown.
Here’s a question worth sitting with for a moment: knowing everything you know today, if you were starting fresh with this money right now, would you invest it in this PMS?
Not “does the return number look good.”
Not “is the fund manager credible” — he clearly is. Just — starting clean, today, with only the public information available to you, would you write this cheque?
This is a different version of the test than you’d apply to a decade-old strategy, because there’s no sunk cost or inertia to cut through here — if you’re reading this before investing, every part of the decision is still in front of you.
The performance case is genuinely strong for a young fund. The open questions aren’t about performance — they’re about detail that isn’t publicly published: the exact stock count, the sector mix, the top holdings, and how this strategy behaves through a real correction, which it hasn’t yet been through.
None of that means the fund is hiding anything — many PMS providers hold this detail back from public platforms and share it directly with clients on request, and a direct conversation with JM Financial is the right way to get it.
If your answer is “yes, but I’d want the fuller portfolio detail from the manager first, and I’d size the position modestly given how young the track record is” — that’s a reasonable, informed answer.
Either way, the point of this test is to make sure the decision is being made on what you actually know, not on a strong headline return number alone.
| Decision Factor | Rating | Analysis |
|---|---|---|
| Uniqueness vs existing MF portfolio | 🟡 | A flexi-cap PMS operates in the same broad universe — large, mid and small caps, no fixed allocation — as your existing flexi-cap and multi-cap mutual funds. That overlap risk is structurally higher than a concentrated small or thematic mandate would carry. Holdings, sector weights and stock count aren’t publicly published for this strategy, so genuine differentiation from your existing funds should be confirmed directly with JM Financial as part of due diligence, rather than assumed either way. |
| Alpha consistency across all periods | 🟢 | This is the standout strength of this review. Alpha is positive over every disclosed period — 1-year (+11.34%), 2-year (+3.25%) and 3-year (+4.95%) — with no negative stretch visible in the data available. That’s a genuinely consistent record for the time the strategy has existed. |
| Justification for PMS fee | 🟡 | The fee structure itself — a choice between 2.50% fixed or 1.00% plus a 20% profit share over a 10% hurdle, with no exit load — is investor-friendly relative to much of the category. Performance so far justifies the fee against both the benchmark and the active category average. The caveat is simply time: three years, entirely within a broadly favourable market backdrop, isn’t enough to confirm the fee is earning its keep across a full cycle. |
| Downside protection in market corrections | 🟡 | There is no period in the disclosed data where the strategy has faced a genuinely negative market environment for an extended stretch — the fund’s own 1-year and 2-year returns are both positive, in a period where the benchmark itself was flat to negative for part of it. That’s encouraging, but it also means downside behaviour in a real correction remains untested and unknown. |
| Portfolio complement for MF investor | 🟡 | The same consideration that affects the uniqueness factor applies here directly. In theory, a quality-plus-momentum overlay could behave quite differently from your existing MF holdings during rotations. Sector tilts and top holdings aren’t publicly published, so this is worth confirming directly with the manager before assuming complementarity. |
| Mandate discipline and specificity | 🟡 | The stated objective — capital appreciation via listed equities, equity-related instruments and ETFs, following a flexi-cap style — is broad and not tightly bounded. There’s no disclosed stock count range, market cap ceiling, or turnover policy of the kind more specific mandates typically publish. That’s not necessarily a flaw in a flexi-cap strategy by design, but it does mean less to hold the manager accountable to over time. |
| Fund manager transparency | 🟢 | Ashish Chaturmohta has a well-documented, verifiable public career — industry recognitions, regular business-media appearances, a long track record as a market analyst. Manager-level transparency is genuinely good. Portfolio-level detail (stock count, average market cap, sector weights) isn’t publicly published — standard practice for a number of PMS providers, who typically share it directly with prospective clients on request. |
| Investment horizon suitability | 🟡 | A quality-plus-momentum approach may behave differently across market regimes than a pure buy-and-hold quality strategy, and SIP/STP availability suggests the manager expects phased entry to matter. With just over three years of history, it’s genuinely too early to say with confidence what holding period this strategy needs to show its full character. |
| Market cap flexibility utilisation | 🟡 | The mandate is explicitly flexi-cap with no stated ceiling, which is appropriate for the category. Without disclosed composition percentages across large, mid and small cap, it isn’t possible to independently confirm how that flexibility has actually been used. |
| Concentration vs diversification visibility | 🟡 | Total number of stocks and top-5 stock and sector weights aren’t publicly published for this strategy. This isn’t a rating of the concentration itself — it’s a note that this detail should be requested directly from JM Financial before forming a view on how concentrated or diversified the portfolio actually is. |
| AUM size and strategy capacity | 🟢 | At ₹638.11 Cr for a flexi-cap mandate that can deploy across the full market cap spectrum, the fund is a manageable size with no apparent capacity constraint at this stage. |
| Manager tenure and continuity risk | 🟡 | Ashish Chaturmohta holds a senior, established position at JM Financial with a long, well-documented career. The specific Apex strategy under his stewardship, however, is only 3 years and 4 months old — strong manager pedigree, but a short strategy-specific track record. |
| Factor | Rating |
|---|---|
| Uniqueness vs MF portfolio | 🟡 |
| Alpha consistency | 🟢 |
| Fee justification | 🟡 |
| Downside protection | 🟡 |
| Portfolio complement | 🟡 |
| Mandate discipline | 🟡 |
| Manager transparency | 🟢 |
| Horizon suitability | 🟡 |
| Market cap flexibility | 🟡 |
| Concentration visibility | 🟡 |
| AUM & capacity | 🟢 |
| Manager tenure/continuity | 🟡 |
Here’s how we think about portfolio construction, and it might be a useful lens for you too: a core built from low-cost, diversified mutual funds — index funds, flexi-cap, multi-asset — should do the heavy lifting of your long-term compounding, cheaply and predictably.
A satellite allocation, including PMS and AIF strategies, only earns its place if it does something your core genuinely cannot: access a market segment, a concentration level, or a thesis your diversified funds structurally can’t reach.
For a young flexi-cap PMS with limited publicly available portfolio detail specifically, the question sharpens further: if you haven’t yet confirmed that the holdings differ meaningfully from your existing flexi-cap or multi-cap mutual fund, is this actually a satellite at all — or could it simply be a second, more expensive core holding sitting in the same lane as one you already own?
That’s a question worth putting directly to JM Financial before sizing a position.
Without pointing at any specific product, here’s what we look for before a satellite allocation earns a place next to a core portfolio:
If you’re weighing whether and how to size a position here, this is what the mechanics look like:
Q1. Is JM Financial’s Apex PMS good or bad?
Its performance so far is genuinely good — consistent positive alpha against the benchmark across all disclosed periods, and a modest edge over the active flexi-cap category average over three years. The open question is track record length, since the strategy is just over three years old; portfolio-level detail like holdings and sector weights isn’t publicly published, and is best confirmed directly with JM Financial.
Q2. What is JM Financial Apex’s AUM?
As of 30th June 2026, the strategy managed approximately ₹638.11 Crore.
Q3. What is the minimum investment for JM Financial Apex PMS?
The minimum investment for JM Financial Apex PMS is ₹50,00,000 (₹50 Lakhs), in line with SEBI’s PMS minimum investment norms.
Q4. What are the fees for JM Financial Apex PMS?
Investors of JM Financial Apex PMS can choose between a 2.50% fixed annual fee, or a 1.00% fixed fee plus a 20% profit share above a 10% hurdle rate of 10%. There is no exit load in any year.
Q5. How has JM Financial Apex performed?
As of 30th June 2026: 9.38% (1-year), 4.77% (2-year), 17.48% (3-year) and 18.76% (since inception, 1 February 2023), against a benchmark (S&P BSE 500 TRI) of -1.96%, 1.52%, 12.53% and 14.23% respectively. The strategy is too young to have a 5-year track record.
Q6. How does JM Financial Apex compare to mutual funds?
Over the last three years, its net return (17.48%) has modestly beaten the average actively managed flexi-cap mutual fund (approximately 16.28%) and beaten the passive benchmark by a wider margin. It has not yet been tested over a longer horizon the way many established flexi-cap mutual funds have.
Q7. Does JM Financial disclose Apex’s portfolio holdings?
Top holdings, sector weights, average market cap and total stock count aren’t publicly published for this strategy. That’s standard practice for a number of PMS providers, who typically share this level of detail directly with prospective and existing clients on request. If it matters to your decision, ask JM Financial for it directly.
Q8. Should I combine PMS and mutual funds in my portfolio?
Often, yes — a low-cost mutual fund core combined with a genuinely differentiated PMS or AIF satellite can be a sound structure. The key word is “genuinely” — the satellite needs to be checked for real overlap, not assumed to be different just because it charges more or performs well in a short window.
We don’t currently recommend JM Financial’s Apex PMS to our clients — not because of its performance, which has genuinely been strong so far, but because a three-year track record isn’t yet enough for us to independently verify how durable this strategy’s edge is across a full market cycle.
We also haven’t yet confirmed the fund’s stock-level portfolio detail directly with JM Financial, which we’d want to do before comparing it against a client’s existing mutual fund holdings.
If you’re already invested in this PMS, or considering it alongside your existing mutual fund portfolio, we’re happy to sit down with you as your CFP, help you request the relevant portfolio detail from JM Financial, and map it against your mutual fund holdings — sector by sector — to see whether the two are likely to complement each other or overlap.
There’s no cost or obligation attached to that conversation; it’s simply the review we’d want done on our own portfolios.
Listen to this article Gold has always occupied a special place in the minds of…
Listen to this article Can the PNB MetLife RISE Plan truly help you build a…
Listen to this article Can the PNB MetLife Smart Invest Pension Plan Pro truly help…
Listen to this article Imagine scrolling through your social media feed when a familiar face…
Listen to this article Every financial system depends on one simple principle—money borrowed should eventually…
Listen to this article Quick Summary What Works What Doesn't Genuinely strong transparency: top 10…